Clinical Trials Directory

Trials / Completed

CompletedNCT02413242

Advanced Understanding of Staphylococcus Aureus and Pseudomonas Aeruginosa Infections in EuRopE - ICU

Status
Completed
Phase
Study type
Observational
Enrollment
2,031 (actual)
Sponsor
Jan Kluytmans · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Intensive Care Unit (ICU) acquired pneumonia, including ventilator-associated pneumonia, is a frequently occurring health-care associated infection, which causes considerable morbidity, mortality and health care costs. Important pathogens causing ICU pneumonia are Staphylococcus aureus and Pseudomonas aeruginosa. The epidemiology of ICU pneumonia and patient-related and contextual factors is not fully described, but is urgently needed to support the development of effective interventions.

Conditions

Interventions

TypeNameDescription
OTHERVarious observed exposure(s) of interestA risk prediction model will be developed to assess which risk factors are associated with the development of ICU pneumonia during ICU stay

Timeline

Start date
2015-04-01
Primary completion
2019-04-30
Completion
2019-04-30
First posted
2015-04-09
Last updated
2019-05-08

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02413242. Inclusion in this directory is not an endorsement.